Ede-Golightly James 4
4 · Silence Therapeutics plc · Filed Dec 22, 2025
Insider Transaction Report
Form 4
Ede-Golightly James
Director
Transactions
- Award
Share Option (Right to Buy)
2025-12-22+90,000→ 90,000 totalExercise: $2.15Exp: 2035-12-22→ Ordinary Shares (90,000 underlying)
Footnotes (1)
- [F1]This option shall vest in equal monthly installments over a one-year period measured from one month following December 22, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date.